Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARIVA: Aspirin and Rivaroxaban for Venous Stent Thrombosis Prevention
NCT04128956Phase 2Terminated
- Sponsor
- University of Zurich
- Start
- Mar 2020
- Primary completion
- Feb 2024
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 2 trial of aspirin in stent thrombosis, sponsored by University of Zurich. Started Mar 2020; status: terminated.
02
Drugs
aspirin
03
Conditions
stent thrombosis
Beyond the preview
Go deeper on NCT04128956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04128956.